Anti-angiogenesis therapy for the treatment of previously treated breast cancer

摘要

This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of 5 human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, in combination with one or more additional anti-tumor therapeutic agents in previously treated metastatic breast cancer. 7721650_1 (GHMatters) P89526.AU.1